Insmed Incorporated

Insmed Incorporated's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Insmed Incorporated has 218.28M shares outstanding.

As of June 30, 2026, Insmed Incorporated maintains a current ratio of 3.72, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 76.55, indicating elevated leverage, while an interest coverage ratio of -10.83 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Insmed Incorporated posted a negative return on equity (ROE) of -87.22, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -38.20, reflecting losses generated across the asset base. The company generates approximately 586,949.18 in revenue per employee across its workforce of 1,565.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.51 indicates how many times Insmed Incorporated sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Insmed Incorporated recorded 5.01M in income tax expense. The company reported a pretax loss of -702.09M and -707.10M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, Insmed Incorporated generated 919.02M in revenue and converted that into -707.10M in net income, yielding earnings per share of -3.30. EBITDA reached -663.06M, while operating income came in at -656.48M.

As of June 30, 2026, Insmed Incorporated holds 937.33M in cash and equivalents against 468.45M in total debt, resulting in a net debt position of -1.01M. Total book value stands at 611.93M, with working capital of 965.50M providing operational flexibility.

Insmed Incorporated produced -629.24M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -23.22M in capital expenditures, free cash flow totaled -652.46M - equivalent to -3.04 per share.

Over the twelve months ended June 30, 2026, Insmed Incorporated posted a gross margin of 83.46, reflecting its pricing power and cost economics. The operating margin of -71.43 and net profit margin of -76.94 provide insight into operational efficiency.

Insmed Incorporated's most recent stock split took place on March 3, 2011 with a 10:1 split ratio.